- Home
- NN vs CERT Comparison
NN vs CERT Comparison
Compare NN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NN
- CERT
- Stock Information
- Founded
- NN 2007
- CERT 2008
- Country
- NN United States
- CERT United States
- Employees
- NN N/A
- CERT N/A
- Industry
- NN Industrial Machinery/Components
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- NN Industrials
- CERT Technology
- Exchange
- NN Nasdaq
- CERT Nasdaq
- Market Cap
- NN 1.9B
- CERT 1.9B
- IPO Year
- NN N/A
- CERT 2020
- Fundamental
- Price
- NN $12.52
- CERT $11.97
- Analyst Decision
- NN
- CERT Buy
- Analyst Count
- NN 0
- CERT 8
- Target Price
- NN N/A
- CERT $15.57
- AVG Volume (30 Days)
- NN 1.3M
- CERT 1.9M
- Earning Date
- NN 11-12-2025
- CERT 11-06-2025
- Dividend Yield
- NN N/A
- CERT N/A
- EPS Growth
- NN N/A
- CERT N/A
- EPS
- NN N/A
- CERT 0.05
- Revenue
- NN $6,259,000.00
- CERT $405,755,000.00
- Revenue This Year
- NN N/A
- CERT $11.70
- Revenue Next Year
- NN N/A
- CERT $8.05
- P/E Ratio
- NN N/A
- CERT $241.27
- Revenue Growth
- NN 42.80
- CERT 11.61
- 52 Week Low
- NN $7.93
- CERT $8.64
- 52 Week High
- NN $18.54
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- NN 24.02
- CERT 48.61
- Support Level
- NN $12.86
- CERT $11.82
- Resistance Level
- NN $13.98
- CERT $12.85
- Average True Range (ATR)
- NN 0.68
- CERT 0.71
- MACD
- NN -0.21
- CERT -0.13
- Stochastic Oscillator
- NN 4.43
- CERT 14.54
About NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.